Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥88,330 | ¥75,579 | ¥67,493 | ¥65,381 |
| % Growth | 16.9% | 12% | 3.2% | – |
| Cost of Goods Sold | ¥44,265 | ¥38,238 | ¥35,118 | ¥34,143 |
| Gross Profit | ¥44,065 | ¥37,341 | ¥32,375 | ¥31,238 |
| % Margin | 49.9% | 49.4% | 48% | 47.8% |
| R&D Expenses | ¥0 | ¥9,474 | ¥10,391 | ¥10,363 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥38,291 | ¥20,790 | ¥20,304 | ¥19,923 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥3,060 | ¥2,808 | ¥2,354 |
| Operating Expenses | ¥38,291 | ¥33,324 | ¥33,503 | ¥32,640 |
| Operating Income | ¥5,774 | ¥4,017 | -¥1,129 | -¥1,402 |
| % Margin | 6.5% | 5.3% | -1.7% | -2.1% |
| Other Income/Exp. Net | ¥9,836 | ¥10,432 | ¥14,809 | ¥17,909 |
| Pre-Tax Income | ¥15,610 | ¥14,449 | ¥13,680 | ¥16,507 |
| Tax Expense | ¥3,634 | ¥3,159 | ¥3,046 | ¥3,475 |
| Net Income | ¥11,961 | ¥11,160 | ¥10,528 | ¥12,921 |
| % Margin | 13.5% | 14.8% | 15.6% | 19.8% |
| EPS | 274.2 | 246.58 | 228.3 | 280.19 |
| % Growth | 11.2% | 8% | -18.5% | – |
| EPS Diluted | 274.2 | 246.58 | 228.3 | 280.19 |
| Weighted Avg Shares Out | 44 | 45 | 46 | 46 |
| Weighted Avg Shares Out Dil | 44 | 45 | 46 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥57 | ¥21 | ¥23 | ¥42 |
| Interest Expense | ¥21 | ¥18 | ¥20 | ¥23 |
| Depreciation & Amortization | ¥4,615 | ¥4,254 | ¥4,109 | ¥3,730 |
| EBITDA | ¥20,250 | ¥18,720 | ¥17,808 | ¥20,261 |
| % Margin | 22.9% | 24.8% | 26.4% | 31% |